abstract |
Compounds of the formula (I), in which R 1a —R 1c , R 2a , R 2b , R 3 and R 5 have the meanings indicated in claim 1 , are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours. |